Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
GSK343 treatment decreased <i>in vivo</i> tumor volume and growth.
Published 2021“…Once tumors were palpable (100 mm<sup>3</sup>), mice were randomized to receive either 100 μL of sterile PBS (vehicle, n = 7) or GSK343 (10 mg/kg/day in 100 μL PBS, n = 7) once daily via intraperitoneal (IP) injection for 21 days. …”
-
32
Cell proliferation was decreased more by combination treatment of SLCP and BBR than individual treatments.
Published 2019“…<p>U-87MG and U-251MG cells were grown in EMEM and 1% pen/strep for 24 h and then treated with either SLCP (20 μM), or BBR (100 μM) or their combination for 24 h, after at which a cell proliferation assay was performed. …”
-
33
-
34
-
35
-
36
Chemokines, with the exception of CXCL1 and MCP-1, decrease acutely following 5 Gy IR.
Published 2024Subjects: -
37
-
38
-
39
Combination treatments increased p53 and decreased c-Myc levels in U-87MG and U-251MG cells more than did single treatments.
Published 2019“…<p>A-C: Western blot data showed that SLCP+BBR increased p53 and decreased c-Myc levels significantly more in U-87MG and U-251MG cells, in comparison to single treatments. …”
-
40